ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 111 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.9%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$164,000
-89.7%
47,849
-95.7%
0.00%
-100.0%
Q3 2020$1,589,000
+3.4%
1,103,707
+43.3%
0.00%0.0%
Q2 2020$1,537,000
+5.4%
770,221
+3.0%
0.00%
-25.0%
Q1 2020$1,458,000
-49.3%
747,669
+8.0%
0.00%
-42.9%
Q4 2019$2,874,000
-61.1%
692,603
+34.6%
0.01%
-74.1%
Q1 2017$7,380,000514,6580.03%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Artal Group S.A. 71,178,364$280,443,0007.61%
BVF INC/IL 14,360,000$56,578,0002.05%
Integral Health Asset Management, LLC 200,000$788,0000.22%
Eversept Partners, LP 797,694$3,142,9140.20%
NEA Management Company, LLC 2,382,286$9,386,0000.19%
PINNACLE ASSOCIATES LTD 2,127,662$8,383,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$141,0000.06%
Virtus ETF Advisers LLC 41,584$164,0000.06%
Pegasus Asset Management, Inc. 10,000$39,0000.02%
GSA CAPITAL PARTNERS LLP 31,562$124,0000.02%
View complete list of LEXICON PHARMACEUTICALS INC shareholders